Consolidated Statements of Operations
 
For the Years Ended December 31,
In millions, except per share amounts
2018
 
2017
 
2016
Revenues:
 
   
   
Products
$
183,910   $
180,063   $
173,377
Premiums
8,184  
3,558  
3,069
Services
1,825  
1,144  
1,080
Net investment income
660  
21  
20
Total revenues
194,579  
184,786  
177,546
Operating costs:
 
   
   
Cost of products sold
156,447  
153,448  
146,533
Benefit costs
6,594  
2,810  
2,179
Goodwill impairments
6,149  
181  
—
Operating expenses
21,368  
18,809  
18,448
Total operating costs
190,558  
175,248  
167,160
Operating income
4,021  
9,538  
10,386
Interest expense
2,619  
1,062  
1,078
Loss on early extinguishment of debt
—  
—  
643
Other expense (income)
(4)  
208  
28
Income before income tax provision
1,406  
8,268  
8,637
Income tax provision
2,002  
1,637  
3,317
Income (loss) from continuing operations
(596)  
6,631  
5,320
Loss from discontinued operations, net of tax
—  
(8)  
(1)
Net income (loss)
(596)  
6,623  
5,319
Net (income) loss attributable to noncontrolling interests
2  
(1)  
(2)
Net income (loss) attributable to CVS Health
$
(594)   $
6,622   $
5,317
 
 
   
   
Basic earnings (loss) per share:
 
   
   
Income (loss) from continuing operations attributable to CVS Health
$
(0.57)   $
6.48   $
4.93
Loss from discontinued operations attributable to CVS Health
$
—   $
(0.01)   $
—
Net income (loss) attributable to CVS Health
$
(0.57)   $
6.47   $
4.93
Weighted average basic shares outstanding
1,044  
1,020  
1,073
Diluted earnings (loss) per share:
 
   
   
Income (loss) from continuing operations attributable to CVS Health
$
(0.57)   $
6.45   $
4.91
Loss from discontinued operations attributable to CVS Health
$
—   $
(0.01)   $
—
Net income (loss) attributable to CVS Health
$
(0.57)   $
6.44   $
4.90
Weighted average diluted shares outstanding
1,044  
1,024  
1,079
Dividends declared per share
$
2.00   $
2.00   $
1.70
 
 
   
   
See accompanying notes to consolidated financial statements.
Page 38___FINANCEBENCH_DELIMITER___Consolidated Balance Sheets
 
At December 31,
In millions, except per share amounts
2018
 
2017
Assets:
 
   
Cash and cash equivalents
$
4,059   $
1,696
Investments
2,522  
111
Accounts receivable, net
17,631  
13,181
Inventories
16,450  
15,296
Other current assets
4,581  
945
Total current assets
45,243  
31,229
Long-term investments
15,732  
112
Property and equipment, net
11,349  
10,292
Goodwill
78,678  
38,451
Intangible assets, net
36,524  
13,630
Separate accounts assets
3,884  
—
Other assets
5,046  
1,417
Total assets
$
196,456   $
95,131
 
 
   
Liabilities:
 
   
Accounts payable
$
8,925   $
8,863
Pharmacy claims and discounts payable
12,302  
10,355
Health care costs payable
5,210  
5
Policyholders’ funds
2,939  
—
Accrued expenses
10,711  
6,581
Other insurance liabilities
1,937  
23
Short-term debt
720  
1,276
Current portion of long-term debt
1,265  
3,545
Total current liabilities
44,009  
30,648
Long-term debt
71,444  
22,181
Deferred income taxes
7,677  
2,996
Separate accounts liabilities
3,884  
—
Other long-term insurance liabilities
8,119  
334
Other long-term liabilities
2,780  
1,277
Total liabilities
137,913  
57,436
Commitments and contingencies (Note 16)
 
 
 
   
Shareholders’ equity:
 
 
 
CVS Health shareholders’ equity:
 
   
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding
—  
—
Common stock, par value $0.01: 3,200 shares authorized; 1,720 shares issued and 1,295 shares outstanding at
December 31, 2018 and 1,712 shares issued and 1,014 shares outstanding at December 31, 2017 and capital
surplus
45,440  
32,096
Treasury stock, at cost: 425 shares at December 31, 2018 and 698 shares at December 31, 2017
(28,228)  
(37,796)
Retained earnings
40,911  
43,556
Accumulated other comprehensive income (loss)
102  
(165)
Total CVS Health shareholders’ equity
58,225  
37,691
Noncontrolling interests
318  
4
Total shareholders’ equity
58,543  
37,695
Total liabilities and shareholders’ equity
$
196,456   $
95,131
 
 
   
See accompanying notes to consolidated financial statements.
Page 40